Sanders Morris Harris’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-21,505
| Closed | -$806K | – | 199 |
|
|
2025
Q1 | $806K | Hold |
21,505
| – | – | 0.12% | 114 |
|
|
2024
Q4 | $1.01M | Hold |
21,505
| – | – | 0.15% | 103 |
|
|
2024
Q3 | $1.14M | Hold |
21,505
| – | – | 0.19% | 76 |
|
|
2024
Q2 | $1.17M | Hold |
21,505
| – | – | 0.19% | 72 |
|
|
2024
Q1 | $1.51M | Hold |
21,505
| – | – | 0.28% | 56 |
|
|
2023
Q4 | $2.29M | Hold |
21,505
| – | – | 1.13% | 20 |
|
|
2023
Q3 | $603K | Hold |
21,505
| – | – | 0.12% | 129 |
|
|
2023
Q2 | $717K | Buy |
+21,505
| New | +$717K | 0.16% | 100 |
|
|
2023
Q1 | – | Sell |
-21,505
| Closed | -$985K | – | 175 |
|
|
2022
Q4 | $985K | Buy |
21,505
+750
| +4% | +$34.4K | 0.37% | 49 |
|
|
2022
Q3 | $1.06M | Sell |
20,755
-1,000
| -5% | -$51.2K | 0.26% | 59 |
|
|
2022
Q2 | $890K | Hold |
21,755
| – | – | 0.19% | 81 |
|
|
2022
Q1 | $801K | Hold |
21,755
| – | – | 0.16% | 103 |
|
|
2021
Q4 | $994K | Hold |
21,755
| – | – | 0.17% | 89 |
|
|
2021
Q3 | $841K | Hold |
21,755
| – | – | 0.15% | 105 |
|
|
2021
Q2 | $425K | Hold |
21,755
| – | – | 0.08% | 197 |
|
|
2021
Q1 | $508K | Hold |
21,755
| – | – | 0.11% | 153 |
|
|
2020
Q4 | $421K | Sell |
21,755
-2,800
| -11% | -$54.2K | 0.1% | 179 |
|
|
2020
Q3 | $413K | Buy |
+24,555
| New | +$413K | 0.11% | 168 |
|
|
2020
Q2 | – | Sell |
-12,155
| Closed | -$145K | – | 138 |
|
|
2020
Q1 | $145K | Buy |
+12,155
| New | +$145K | 0.14% | 110 |
|